Medtronic PLC
Change company Symbol lookup
Select an option...
MDT Medtronic PLC
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
TEAM Atlassian Corporation PLC
PAYX Paychex Inc
FISV Fiserv Inc
PYPL PayPal Holdings Inc
PG Procter & Gamble Co

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Based in Ireland
Company profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Day's Change
0.915 (0.81%)
B/A Size
Day's High
Day's Low

Today's volume of 2,075,719 shares is on pace to be much lighter than MDT's 10-day average volume of 4,378,259 shares.


Forecast [2019-2026], Smart Pills Market Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape Report by Fortune Business Insights(TM)

9:02 am ET October 12, 2020 (Globe Newswire) Print

The global smart pills market is set to gain traction from the increasing usage of these non-invasive devices for the diagnosis of gastrointestinal disorders and cancer. They can ever replace the traditional diagnostic techniques such as endoscopy. Fortune Business Insights(TM) published this information in an upcoming report, titled, "Smart Pills Market Size, Share & Industry Analysis, By Application (Capsule Endoscopy, Targeted Drug Delivery, Vital Sign Monitoring), By End User (Hospital & Specialty Clinics, Diagnostic & Research Centers) and Regional Forecast, 2019-2026." The report further states that smart pills include chemical sensor, pH, or biosensor. When swallowed, they can travel along the gastrointestinal tract for capturing images.

This Report Answers the Following Questions:

-- How will the organizations surge sales of smart pills?

-- Which key players are set to lead the market in the near future?

-- Which segment would dominate the market in the coming years?

-- What are the current challenges and opportunities in the global market?

Request a Sample Copy of the Research Report:

High Prevalence of Gastrointestinal Reflux Diseases to Aid Growth

The rising prevalence of chronic diseases such as breast cancer and colorectal cancer worldwide is set to be a vital driver for the smart pills market growth in the coming years. Additionally, the higher occurrences of lifestyle-related disorders, namely, gastric ulcers and gastrointestinal reflux diseases (GERD) would also affect growth positively. Hence, people nowadays are shifting towards innovative treatment options.

Moreover, patients prefer minimally invasive procedures more than the conventional treatment options. This factor is expected to surge the demand for smart pills in the forthcoming years. Also, smart pills have certain beneficial properties, such as easy remote patient monitoring, targeted drug delivery, and advanced capsule endoscopy. However, they are expensive and this, in turn, may hinder growth.

The outbreak of the COVID-19 pandemic has shattered the economy worldwide. Many hospitals are exhibiting a lower number of beds for coronavirus positive patients. Until and unless a vaccine is discovered, we are unable to estimate the timeline up to when this situation would continue. Our elaborate research reports will help you in generating more revenues by choosing the correct strategy.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

Increasing Awareness Programs about Lifestyle Related Diseases to Favor Growth in Europe

Regionally, North America is likely to remain in the dominant position throughout the near future by earning the largest smart pills market share. This growth is attributable to the presence of favorable reimbursement policies, rising usage of novel technologies, and higher cases of cancer in the region. The American Cancer Society mentioned that in the U.S., approximately, 43,340 new cases of colorectal cancer are detected every year. This is a prominent factor that would boost growth in this region.

Europe, on the other hand, is set to exhibit a significant CAGR in the forthcoming period on account of the increasing awareness programs about lifestyle related diseases. Also, the increasing healthcare expenditure is anticipated to aid growth. Asia Pacific is likely to grow considerably backed by the major contributions of Australia, China, and Japan.

Key Players Focus on Launching Innovative Smart Pills to Gain a Competitive Edge

The market for smart pills is highly fragmented. Most of the companies nowadays are conducting extensive research programs to come up with state-of-the-art products. They are doing so to gain a competitive edge. Some of the others are engaging in the strategy of mergers & acquisitions to strengthen their product portfolios. Below are a couple of the latest industry developments:

-- August 2020: Otsuka is set to acquire Proteus Digital Health, its digital pill partner for USD 15 million. The transaction was approved by a U.S. bankruptcy court based in Delaware. The deal had previously faced multiple objections from a group of investors, including Novartis.

-- August 2020: Emme introduced Smart Case, its innovative birth control adherence device. It can detect whether a woman has taken her birth control pill by using the multisensor technology. It works with more than 100 brands of pills and costs $99.

Have Any Query? Ask Our Experts:

Fortune Business Insights(TM) lists out the names of all the renowned manufacturers operating in the global smart pills market. They are as follows:

-- Proteus Digital Health

-- Medtronic

-- CapsoVision, Inc.

-- Olympus Corporation

-- Otsuka Pharmaceutical Co., Ltd.


-- Other renowned companies

Get your Customized Research Report:

Global Smart Pills Market Segmentation:

By Application

? Capsule Endoscopy

? Targeted Drug Delivery

? Vital Sign Monitoring

By End User

? Hospital & Specialty Clinics

? Diagnostic & Research Centers

By Geography

? North America (USA, Canada)

? Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

? Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

? Latin America (Brazil, Mexico, Rest of Latin America)

? Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Have a Look at Related Reports:

Spinal Muscular Atrophy (SMA) Treatment Market Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2019-2026

Venous Leg Ulcer (VLU) Treatment Market Share and Industry Analysis, By Product (Compression Therapy, Advanced Wound Dressings, Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), and Regional Forecast, till 2026

Animal Health Market Share and Industry Analysis By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast, 2019-2026

Dry Eye Syndrome Market Share & Industry Analysis, By Product (Anti-inflammatory and, Artificial Tears and Lubricants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2019-2026

Ocular Implants Market Share & Industry Analysis, By Product Type (Intraocular Lenses, Glaucoma Implants, Ocular Prostheses, Corneal Implants, and Others), By End-user (Hospitals, Ophthalmic Clinics, and Others), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245


Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.